CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
113 hedge funds and large institutions have $216M invested in Cymabay Therapeutics in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 38 increasing their positions, 26 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
113
Holders Change
–
Holders Change %
0%
% of All Funds
1.75%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
24
Increased
38
Reduced
26
Closed
24
Calls
$1.38M
Puts
$1.99M
Net Calls
-$607K
Net Calls Change
+$702K
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Principal Financial Group
Des Moines,
Iowa
| – | -$50K | -13,684 | Closed |
|
127
Simplex Trading
Chicago,
Illinois
| – | -$49K | -11,198 | Closed |
|
|
RJFSA
128
Raymond James Financial Services Advisors
St. Petersburg,
Florida
| – | -$40K | -11,091 | Closed |
|
129
AQR Capital Management
Greenwich,
Connecticut
| – | -$39K | -10,578 | Closed |
|
|
LCM
130
LCM Capital Management
Chicago,
Illinois
| – | -$37K | -10,000 | Closed |
|
|
S
131
SignatureFD
Atlanta,
Georgia
| – | -$28K | -7,700 | Closed |
|
|
PCM
132
Penserra Capital Management
Orinda,
California
| – | -$5K | -1,580 | Closed |
|
|
PHK
133
Point72 Hong Kong
Hong Kong
| – | -$2K | -610 | Closed |
|